Fig. 1From: Comparative risk of incidence and clinical outcomes of COVID-19 among proton pump inhibitor and histamine-2 receptor antagonist short-term users: a nationwide retrospective cohort studyFlowchart in the primary analysis of PPI use and risk of COVID 19Back to article page